Listed

BlackRock, Inc.

BLKNYSECIK 2012383FinancialsFiscal year ends Dec 31

Reports and events: 37 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BlackRock, Inc., Reports and events
FiledFormWhat it isAccession number
2026-10-1406:39 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-420979
2026-08-0610:57 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-337177
2026-07-1506:33 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-304013
2026-06-3017:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-290830
2026-05-2216:30 ET8-K5.07 Shareholder vote results0001193125-26-237027
2026-05-0615:25 ET10-QQuarterly reportPeriod 2026-03-310001193125-26-208766
2026-04-1406:35 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-153768
2026-04-1016:30 ETDEF 14AProxy statementPeriod 2026-05-200001308179-26-000262
2026-04-0316:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-26-142112
2026-02-2516:57 ET10-KAnnual reportPeriod 2025-12-310001193125-26-071966
2026-01-2716:29 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-024549
2026-01-1616:21 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-015405
2026-01-1506:36 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-013503
2025-11-0516:29 ET10-QQuarterly reportPeriod 2025-09-300001193125-25-267043
2025-10-1410:38 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-25-237960
2025-08-0617:46 ET10-QQuarterly reportPeriod 2025-06-300000950170-25-103780
2025-07-1510:40 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-095711
2025-07-0113:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-153573
2025-05-1619:17 ET8-K5.07 Shareholder vote results0001193125-25-121622
2025-05-0720:51 ET10-QQuarterly reportPeriod 2025-03-310000950170-25-065838
2025-04-1110:40 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-053022
2025-04-0722:13 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-25-073567
2025-04-0420:10 ETDEF 14AProxy statementPeriod 2025-05-150001308179-25-000388
2025-04-0320:53 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-25-072429
2025-03-2620:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-064112
2025-03-0321:41 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-044184
2025-02-2520:59 ET10-KAnnual reportPeriod 2024-12-310000950170-25-026584
2025-02-1413:57 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-026705
2025-01-2200:00 ETSCHEDULE 13DOwnership report, active investor0000950170-25-007970
2025-01-1521:32 ET8-K5.02 Departure or appointment of officers or directors0001193125-25-007063
2025-01-1511:44 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-25-005629
2024-12-0311:09 ET8-K3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-269350
2024-11-2721:57 ETSC 13D/AOwnership report, active investor, amended0001341004-24-000229
2024-11-1922:19 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-24-261807
2024-11-0821:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-24-254116
2024-11-0621:09 ET10-QQuarterly reportPeriod 2024-09-300000950170-24-122256
2024-10-1110:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-114208

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:31 ET. Listed shows no prices and gives no investment advice.